Remove DNA Remove Targeted Protein Degradation Remove Treatment
article thumbnail

Antibody-drug conjugates payloads: then, now and next

Drug Target Review

Antibody-drug conjugates (ADCs) have been a groundbreaking approach to cancer treatment with their ability to deliver cytotoxic drugs directly to diseased cells while sparing healthy tissues. This targeted delivery allows enhanced therapeutic efficacy while reducing the harmful side effects commonly associated with traditional chemotherapy.

article thumbnail

A New Wave of Therapeutic Innovation Through Targeting Transcription Factors

LifeSciVC

While the successful therapeutic targeting of transcription factors is a relatively new undertaking by industry, these proteins themselves are nothing new. One area of interest is that of oncology, where growing evidence has shown the role that transcription factors play in driving various cancers.